Long-Term Outcome of Prenatal Dexamethasone Treatment of 21-Hydroxylase Deficiency

2010 ◽  
pp. 96-105 ◽  
Author(s):  
Svetlana Lajic ◽  
Anna Nordenström ◽  
Tatja Hirvikoski
Keyword(s):  
Dexamethasone Treatment ◽  
Hydroxylase Deficiency ◽  
Term Outcome ◽  
Long Term Outcome ◽  
21 Hydroxylase Deficiency

Long-Term Outcome of Patients With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency

2012 ◽  
Vol 344 (5) ◽  
pp. 363-373 ◽  
Author(s):  
Mouna Feki Mnif ◽  
Mahdi Kamoun ◽  
Fatma Mnif ◽  
Nadia Charfi ◽  
Nozha Kallel ◽  
...  
Keyword(s):  
Congenital Adrenal Hyperplasia ◽  
Adrenal Hyperplasia ◽  
Hydroxylase Deficiency ◽  
Term Outcome ◽  
Long Term Outcome ◽  
21 Hydroxylase Deficiency

Long-Term Outcome of Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

2006 ◽  
Vol 67 (6) ◽  
pp. 268-276 ◽  
Author(s):  
Anne Bachelot ◽  
Geneviève Plu-Bureau ◽  
Elisabeth Thibaud ◽  
Kathleen Laborde ◽  
Graziella Pinto ◽  
...  
Keyword(s):  
Congenital Adrenal Hyperplasia ◽  
Adrenal Hyperplasia ◽  
Hydroxylase Deficiency ◽  
Term Outcome ◽  
Long Term Outcome ◽  
21 Hydroxylase Deficiency

scholarly journals The Success of a Screening Program Is Largely Dependent on Close Collaboration between the Laboratory and the Clinical Follow-Up of the Patients

2020 ◽  
Vol 6 (3) ◽  
pp. 68 ◽  
Author(s):  
Svetlana Lajic ◽  
Leif Karlsson ◽  
Rolf H. Zetterström ◽  
Henrik Falhammar ◽  
Anna Nordenström
Keyword(s):  
Screening Program ◽  
Hydroxylase Deficiency ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Initial Care ◽  
Swedish Experience ◽  
21 Hydroxylase Deficiency ◽  
Source Of Information

Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency is now performed in an increasing number of countries all over the world. The main goal of the screening is to achieve early diagnosis and treatment in order to prevent neonatal salt-crisis and death. The screening laboratory can also play an important role in increasing the general awareness of the disease and act as the source of information and education for clinicians to facilitate improved initial care, ensure prompt and correct glucocorticoid dosing to optimize the long-term outcome for the patients. A National CAH Registry and CYP21A2 genotyping provide valuable information both for evaluating the screening program and the clinical outcome. The Swedish experience is described.

Long-term outcome of treatment with cyclosporine IV for patients with intractable ulcerative colitis

2001 ◽  
Vol 120 (5) ◽  
pp. A624-A624 ◽  
Author(s):  
J ARTS ◽  
M ZEEGERS ◽  
G DHAENS ◽  
G VANASSCHE ◽  
M HIELE ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Term Outcome ◽  
Long Term Outcome
Sign in / Sign up

Export Citation Format

Share Document